DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended September 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166 0080] [Party A: Beijing De-haier Technology Co. Ltd. (hereinafter referred as “Party A”) Party B: Beijing Dehaier Medical Technology Co., Ltd. (hereinafter referred as “Party B”) Party A and Party B have achieved mutual agreements on the following items: I Location 45 Yong An Road, Science Park, Changping District Beijing (102200) 1,800 Party A agrees to lease space at II Leasing] [Sales Agency Agreement 1. Contracting Parties Supplier hereinafter called “party A” IMD China Co., Ltd. Address: 1-2 Floor Building 12, No. 28 Yuhua Road, Area B. Beijing Tianzhu Airport Industrial Zone, Beijing China Agent hereinafter called “party B” Beijing DeHaier Medical Technology Co., Ltd. Address: 1223 Epoch Center 31 Zizhuyuan Road, Haidian District, Beijing, China IMD Beijing DeHaier to act] [Timesco of London Ltd Timesco House, 3 Carnival Park Carnival Close, Basildon Essex SS14 3WN, England T: +44 (0) 1268 297 700 F: +44 (0) 1268 297 800 info@timesco.com E: www.timesco.com INSTRUMENTS FOR LIFE Letter of Authorization th 10 Please treat this letter as authorization for Beijing De-Haier Medical Technology Co. Ltd to be a distributor for Timesco Laryngoscopes in] [Sales Agency Agreement Contracting Parties Supplier Agent (hereinafter called "party B"): Beijing DeHaier Medical Technology Co., Ltd. I General I. product distributor two of JMS Syringe pump & Infusion pump. Beijing DeHaier to act as JMS's 2. of According to different limits a. of p of General distributor: Party A authorizes Party B to distribute certain type or certain range] [Borrower: Beijing Dehaier Medical Technology Company Limited Lender: ICBC Beijing (Fangzhuang Branch) Purpose of Line of Credit 1. The purpose of the line of credit is to allow the Borrower to finance its working capital needs (including equipment purchases). Amount of Line of Credit 2. RMB10,000,000 Line of Credit Term 3. The line of credit shall run from June 20,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Xiaoqing Wang Party B: July 8, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Xiaoqing Wang Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Yanying (Aileen) Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Yanying (Aileen) Qi Yanying (Aileen) Qi Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-25T08:46:10+00:00 November 10th, 2011|Categories: Chinese Stocks, DHRM, SEC Original|Tags: , , , , , |0 Comments
Read More

DHRM [Dehaier Medical Systems] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended September 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza 15 West 4th Ring North Road Haidian District, Beijing 100195 People’s Republic of China +86 (10) 5166 0080] [Party A: Beijing De-haier Technology Co. Ltd. (hereinafter referred as “Party A”) Party B: Beijing Dehaier Medical Technology Co., Ltd. (hereinafter referred as “Party B”) Party A and Party B have achieved mutual agreements on the following items: I Location 45 Yong An Road, Science Park, Changping District Beijing (102200) 1,800 Party A agrees to lease space at II Leasing] [Sales Agency Agreement 1. Contracting Parties Supplier hereinafter called “party A” IMD China Co., Ltd. Address: 1-2 Floor Building 12, No. 28 Yuhua Road, Area B. Beijing Tianzhu Airport Industrial Zone, Beijing China Agent hereinafter called “party B” Beijing DeHaier Medical Technology Co., Ltd. Address: 1223 Epoch Center 31 Zizhuyuan Road, Haidian District, Beijing, China IMD Beijing DeHaier to act] [Timesco of London Ltd Timesco House, 3 Carnival Park Carnival Close, Basildon Essex SS14 3WN, England T: +44 (0) 1268 297 700 F: +44 (0) 1268 297 800 info@timesco.com E: www.timesco.com INSTRUMENTS FOR LIFE Letter of Authorization th 10 Please treat this letter as authorization for Beijing De-Haier Medical Technology Co. Ltd to be a distributor for Timesco Laryngoscopes in] [Sales Agency Agreement Contracting Parties Supplier Agent (hereinafter called "party B"): Beijing DeHaier Medical Technology Co., Ltd. I General I. product distributor two of JMS Syringe pump & Infusion pump. Beijing DeHaier to act as JMS's 2. of According to different limits a. of p of General distributor: Party A authorizes Party B to distribute certain type or certain range] [Borrower: Beijing Dehaier Medical Technology Company Limited Lender: ICBC Beijing (Fangzhuang Branch) Purpose of Line of Credit 1. The purpose of the line of credit is to allow the Borrower to finance its working capital needs (including equipment purchases). Amount of Line of Credit 2. RMB10,000,000 Line of Credit Term 3. The line of credit shall run from June 20,] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Yanying Qi Party B: September 30, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Yanying Qi Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [Labor Contract Beijing Dehaier Medical Technology Company Limited Party A: Xiaoqing Wang Party B: July 8, 2011 LABOR CONTRACT Beijing Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: Xiaoqing Wang Identification Card No.: (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Yanying (Aileen) Qi, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Yanying (Aileen) Qi Yanying (Aileen) Qi Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-25T08:47:20+00:00 November 10th, 2011|Categories: Chinese Stocks, DHRM, Webplus ver|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2011 -------------------------------- President and Chief Executive Officer cphi10qex321093011.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093011.htm 5 EX-32.2]

By | 2016-02-07T22:37:27+00:00 November 10th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2011

[FORM 10-Q (Mark One) x September 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2011 -------------------------------- President and Chief Executive Officer cphi10qex321093011.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093011.htm 5 EX-32.2]

By | 2016-02-07T22:38:24+00:00 November 10th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CGA [China Green Agriculture] 10-Q:

[] [CERTIFICATION I, Tao Li certify that: 1. I have reviewed this report on Form 10-Q of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Ken Ren, certify that: 1. I have reviewed this report on Form 10-Q of China Green Agriculture, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (principal financial officer and principal accounting officer)]

By | 2016-03-19T01:04:20+00:00 November 9th, 2011|Categories: CGA, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

ONP [Orient Paper] 10-Q: (Original Filing)

[TABLE OF CONTENTS Page PART I Item 1. Financial Statements. 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation. 19 Item 3. Quantitative and Qualitative Disclosures About Market Risk. 34 Item 4. Controls and Procedures. 35 PART II Item 1. Legal Proceedings. 35] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial andaccounting officer)]

By | 2016-03-19T23:57:56+00:00 November 9th, 2011|Categories: Chinese Stocks, ONP, SEC Original|Tags: , , , , , |0 Comments
Read More

ONP [Orient Paper] 10-Q: TABLE OF CONTENTS Page PART I Item 1.

[TABLE OF CONTENTS Page PART I Item 1. Financial Statements. 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation. 19 Item 3. Quantitative and Qualitative Disclosures About Market Risk. 34 Item 4. Controls and Procedures. 35 PART II Item 1. Legal Proceedings. 35] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial andaccounting officer)]

By | 2016-03-19T23:59:30+00:00 November 9th, 2011|Categories: Chinese Stocks, ONP, Webplus ver|Tags: , , , , , |0 Comments
Read More

SYUT [Synutra International] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended September 30, 2011 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o o Large accelerated filer x Accelerated filer] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Weiguo Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]

By | 2016-03-18T18:47:55+00:00 November 9th, 2011|Categories: Chinese Stocks, SEC Original, SYUT|Tags: , , , , , |0 Comments
Read More

SYUT [Synutra International] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended September 30, 2011 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o o Large accelerated filer x Accelerated filer] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Weiguo Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]

By | 2016-03-18T18:49:34+00:00 November 9th, 2011|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: , , , , , |0 Comments
Read More

KGJI [KINGOLD JEWELRY] 10-Q: (Original Filing)

[FORM 10-Q þ For the quarterly period ended: September 30, 2011 ¨ For the transition period from: _____________ to _____________ KINGOLD JEWELRY, INC. Delaware 001-15819 13-3883101 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) 15 Huangpu Science and Technology Park Jiang’an District Wuhan, Hubei Province, PRC 430023 (011) 86 27 65694977 (Former name, former address and former] [] [] [] [] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Zhihong Jia, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Bin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Zhihong Jia Chairman, Chief Executive Officer and] [CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Bin Liu Chief Financial Officer and Principal Accounting Officer]

By | 2016-03-16T18:09:19+00:00 November 9th, 2011|Categories: Chinese Stocks, KGJI, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar